Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Albini

Showing results (1-10 of 182) with videos related to

Pageof 19
Sort By:
Developments in Ophthalmology|October 27, 2015
Ocular Immunity and InflammationThomas A Albini, Janet L Davis
Current Opinion in Ophthalmology|March 26, 2021
Drug-related adverse effects of antivascular endothelial growth factor agentsPrashanth G Iyer, Thomas A Albini
JAMA Ophthalmology|April 10, 2015
Syphilitic posterior uveitisChristina Y Weng, Thomas A Albini
Ophthalmic Surgery, Lasers & Imaging Retina|April 12, 2016
8 Questions with Dr. Puliafito. Interview with Thomas A. Albini, MDThomas A Albini, Carmen A Puliafito
International Ophthalmology Clinics|June 26, 2022
Review of Intraocular Inflammation After Antivascular Endothelial Growth Factor AgentsPrashanth G Iyer, Thomas A Albini
Journal of Ophthalmology|August 21, 2014
Sustained-release corticosteroid optionsMariana Cabrera, Steven Yeh, Thomas A Albini
International Ophthalmology Clinics|June 3, 2015
Intraocular Sustained-release Steroids for UveitisNidhi Relhan, Steven Yeh, Thomas A Albini
Retina (Philadelphia, Pa.)|August 12, 2014
Diagnostic and Therapeutic ChallengesOlga Furashova, Egbert Matthè, Thomas A Albini
Journal of Ophthalmic Inflammation and Infection|April 14, 2026
Relapse of retinal vasculitis after a non-medical biosimilar switch: a case reportGeorges AbouKasm, Charles Zhang, Thomas A Albini
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 20, 2010
Ocular complication of intense pulsed light therapy: iris photoablationGolnaz Javey, Stephen G Schwartz, Thomas A Albini
Pageof 19

Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
Developments in Ophthalmology|October 27, 2015
Ocular Immunity and InflammationThomas A Albini, Janet L Davis
Current Opinion in Ophthalmology|March 26, 2021
Drug-related adverse effects of antivascular endothelial growth factor agentsPrashanth G Iyer, Thomas A Albini
JAMA Ophthalmology|April 10, 2015
Syphilitic posterior uveitisChristina Y Weng, Thomas A Albini
Ophthalmic Surgery, Lasers & Imaging Retina|April 12, 2016
8 Questions with Dr. Puliafito. Interview with Thomas A. Albini, MDThomas A Albini, Carmen A Puliafito
International Ophthalmology Clinics|June 26, 2022
Review of Intraocular Inflammation After Antivascular Endothelial Growth Factor AgentsPrashanth G Iyer, Thomas A Albini
Journal of Ophthalmology|August 21, 2014
Sustained-release corticosteroid optionsMariana Cabrera, Steven Yeh, Thomas A Albini
International Ophthalmology Clinics|June 3, 2015
Intraocular Sustained-release Steroids for UveitisNidhi Relhan, Steven Yeh, Thomas A Albini
Retina (Philadelphia, Pa.)|August 12, 2014
Diagnostic and Therapeutic ChallengesOlga Furashova, Egbert Matthè, Thomas A Albini
Journal of Ophthalmic Inflammation and Infection|April 14, 2026
Relapse of retinal vasculitis after a non-medical biosimilar switch: a case reportGeorges AbouKasm, Charles Zhang, Thomas A Albini
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 20, 2010
Ocular complication of intense pulsed light therapy: iris photoablationGolnaz Javey, Stephen G Schwartz, Thomas A Albini
Pageof 19